Ekso Bionics Holdings, Inc. (EKSO) Financials
EKSO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 28.9 million | 16.3 million |
2023-09-30 | 31.2 million | 15.9 million |
2023-06-30 | 34.0 million | 16.2 million |
2023-03-31 | 37.1 million | 15.8 million |
EKSO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -1.6 million | 553000 |
2023-09-30 | -3.4 million | 526000 |
2023-06-30 | -3.0 million | 640000 |
2023-03-31 | -4.3 million | 517000 |
EKSO Net Income
No data available :(
EKSO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 8.6 million | - | 1.1 million |
2023-09-30 | 9.9 million | - | 1.2 million |
2023-06-30 | 13.3 million | - | 1.3 million |
2023-03-31 | 16.3 million | - | 1.3 million |
EKSO Shares Outstanding
EKSO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 43000 | 1.3 million | 2.5 million | 2.0 million |
2023-09-30 | 17000 | 1.2 million | 2.2 million | 2.1 million |
2023-06-30 | 55000 | 1.4 million | 2.8 million | 2.3 million |
2023-03-31 | 42000 | 1.2 million | 3.2 million | 2.1 million |
EKSO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 4.8 million | 2.5 million |
2023-09-30 | 4.6 million | 2.2 million |
2023-06-30 | 4.7 million | 2.4 million |
2023-03-31 | 4.1 million | 2.1 million |
EKSO
Price: $1.36
52 week price:
Earnings Per Share: -1.10 USD
P/E Ratio: -1.79
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 30100
Ebitda: -6.6 millionMarket Capitalization: 23.8 million